Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01141920 · ClinicalTrials.gov registry record · NA

Comparison of Two Counseling Induction Strategies

A NA study of Drug Use Disorders and Methadone, sponsored by Johns Hopkins University.

Completed
Registry status
NA
Development phase
120
Enrollment target
1
Study location

NCT01141920: Completed NA study of Drug Use Disorders and Methadone, sponsored by Johns Hopkins University.

NCT01141920 is a NA study of Drug Use Disorders and Methadone that has completed, run by Johns Hopkins University. The registered enrollment target is 120 participants, below the 2,715-participant average among 5 other Drug Use Disorders trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01141920, a NA study of Drug Use Disorders and Methadone, has completed, sponsored by Johns Hopkins University.

COMPLETED
Registry status
NA
Development phase
120 participants
Enrollment target
1
Study location

Study Summary

New admissions (n = 120) to the Addiction Treatment Services (ATS) will be stabilized on methadone and randomly assigned to one of two induction conditions: 1) routine stepped care, or 2) low threshold stepped care. All participants will continue with routine stepped care in month 4. Treatment retention is the primary outcome measure, while drug use (measured via weekly urinalysis testing) is the major secondary outcome.

Primary Outcome

The number of days patients remained in treatment over the 120 day study.

Interventions

  • BEHAVIORAL low threshold care
  • BEHAVIORAL stepped-based care

Study Locations (1)

Maryland

  • Addiction Treatment Services -- Hopkins Bayview - Baltimore

Trial Details

FieldValue
Enrollment Target 120 participants
Start Date 2008-09
Est. Completion 2009-09
Phase NA
Johns Hopkins University

1,448 total trials

What the finished NCT01141920 record still lists

NCT01141920 is an interventional study that assigns participants to a tested intervention. The registered 120 participants enrollment target is mid-sized for trials with a published cap, below the 2,715-participant average among 5 other Drug Use Disorders trials with a reported enrollment target (96% lower).

The record links to 2 conditions, with Drug Use Disorders appearing as the primary indexed condition, and to 2 interventions - of which low threshold care is the first listed.

NCT01141920 reports a single indexed study location in Maryland.

Frequently Asked Questions

What is clinical trial NCT01141920 about?

NCT01141920 is a clinical study titled "Comparison of Two Counseling Induction Strategies". New admissions (n = 120) to the Addiction Treatment Services (ATS) will be stabilized on methadone and randomly assigned to one of two induction conditions: 1) routine stepped care, or 2) low threshold stepped care. All participants will continue with routine stepped care in month 4. Treatment reten...

What is the current status of trial NCT01141920?

This trial is currently completed. It is a NA study. The enrollment target is 120 participants. The study started on 2008-09. Estimated completion is 2009-09.

What conditions does trial NCT01141920 study?

This clinical trial studies the following conditions: Drug Use Disorders, Methadone.

What interventions are being tested in trial NCT01141920?

The interventions under investigation include: low threshold care (BEHAVIORAL), stepped-based care (BEHAVIORAL).

Who is sponsoring clinical trial NCT01141920?

This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01141920 being conducted?

This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Drug Use Disorders

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01174108 · 120 participants · Phase 2

    Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells

  • NCT01627301 · 120 participants · NA

    Sympathetic Overactivity in Post-traumatic Stress Disorder

  • NCT02025023 · 120 participants · Phase 3

    Local 5-Fluorouracil Injection for the Treatment of Chalazia: A Prospective, Comparative Study

  • NCT02128906 · 120 participants · Phase 2

    Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01141920, the US trial registry maintained by the National Library of Medicine. NCT01141920 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.